Worldwide rates of either HSV-1 and/or HSV-2 are between 60 and 95% in adults [REF].
In British Columbia in 1999, the seroprevalence of HSV-2 antibody in leftover serum submitted for antenatal testing revealed a prevalence of 17%, ranging from 7% in women 15-19 years old to 28% in those 40-44 years [REF].